Don Davies on Questions Passed as Orders for Return

With regard to anticipated outcomes by the government related to the Public Health Agency of Canada’s HIV and Hepatitis C Community Action Fund: (a) how, by whom, and when will the amount of the “transition-based funding” to be provided, in each instance, be determined; (b) will the “transition-based funding” to be received by each funded organization be equal to the full amount payable to it for the 2016-2017 fiscal year under the current contracts, and if not, what amount of “transition-based funding” will each group be eligible for; (c) will any currently funded activities no longer be fundable under the “transition-based funding”, and, if so, which ones; (d) as the “transition-based funding” is to be provided for the purpose of addressing “gaps in priority areas”, how, and by whom, and using what criteria, will those gaps and priority areas be identified and assessed; (e) will currently contracted organizations eligible for “transition-based funding” be permitted any input into assessments regarding “gaps in priority areas” and consequent decisions; (f) is there to be any difference between the process and associated “transition-based funding” to be accorded to organizations approved for projects at lower amounts than current funding on the one hand and organizations that were unsuccessful in the application process on the other and, if so, what will those differences be; (g) what further opportunities to secure renewed or new contract funding will be accorded to the affected organizations during the 2017-2018 “transition year”; (h) how will provincial and territorial Ministries of Health and health authorities be engaged in this transition funding review process and decision making; (i) to what extent will decisions regarding fundable activities be based on areas previously identified by provincial and territorial governments as geographic and population gaps; (j) from what source will the “transition-based funding” be drawn; (k) will consumer organizations dedicated to Hepatitis C Virus Mono-Infection issues be considered for “transition-based funding” regardless of whether or not they were previously funded by PHAC, and will there be any opportunity for such organizations to seek further future funding during the next fiscal year; (l) will there be any funding available to assist in addressing identified gaps after March 31, 2018; (m) what further opportunities to secure renewed or new contract funding will be provided to impacted organizations during the 2017-2018 “transition year”; (n) when will the next Public Health Agency of Canada funding call occur for the HIV and Hepatitis C Community Action Fund; (o) of the 224 project submissions received by the Public Health Agency of Canada following an open call for Letters of Intent (LOI), which organizations were (i) invited to submit full project proposals with no changes required, (ii) invited to submit a full application at a reduced budget amount, (iii) not recommended for further consideration; (p) for organizations invited to submit a full application at a reduced budget amount, what is the dollar value of each reduction; and (q) for every LOI received, what was (i) the name of the organization or organizations submitting it, (ii) the response provided to item twenty of the Letter solicitation; (r) what criteria were used to evaluate LOIs in the review process; (s) what were the qualifications of reviewers evaluating LOIs; (t) to what extent were people with lived experience involved in the LOI review process; (u) what regions of Canada do those who were involved in the LOI review process reside in; and (v) how were Indigenous people engaged in the review process?